Greetings, and welcome to the Gentherm First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host Gregory Blanchette, Senior Director, Investor Relations. Thank you. You may begin.

Thank you. Good morning, everyone, and thanks for joining us today. Gentherm's earnings results were released earlier this morning, and a copy of the release is available at gentherm.com. Additionally, a webcast replay of today's call will be available later today on the Investor Relations section of Gentherm's website. During this call, we will make forward-looking statements within the meaning of federal securities laws. These statements reflect our current views with respect to future events and financial performance, and actual results may differ materially. We undertake no obligation to update them, except as required by law. Please see Gentherm's earnings release and its SEC filings, including the latest 10-K and subsequent reports, for discussions of our risk factors and other significant assumptions, risks and uncertainties underlying such forward-looking statements. During the call, we will also discuss non-GAAP financial measures as defined by SEC Regulation G. Reconciliations of these non-GAAP financial measures to the comparable GAAP financial measures are included in our earnings release and investor presentation. On the call with me today are Bill Presley, President and Chief Executive Officer; and Jon Douyard, Chief Financial Officer. During their comments, they will be referring to a presentation deck that we made available on the Investor section of Gentherm's website. After the prepared remarks, we'd be pleased to take your questions. Now, I'd like to turn the call over to Bill.

Thank you, Greg, and good morning, everyone. I'm excited to give you an update on our first quarter, the opportunities across Gentherm, and the progress we've made in the short period since joining the company at the beginning of the year. I am pleased with the energy and adaptability of the Gentherm team. The team has worked aggressively to begin instituting key business process standardization actions and embrace the challenge of pushing our core platforms into markets outside of automotive. We are aligned on the need to grow revenue while expanding margins and increasing cash flow. We as a company are still in the early stages of this journey, but I see great opportunities ahead for us. Let me start with some comments on the broader operating environment on slide three before diving into our business. The announcement of tariffs has created an increased level of economic uncertainty. We continue to monitor developments related to tariffs daily with an internal team and have also engaged various industry partners to help us fully understand any potential impact. We have a strategically positioned footprint focused primarily on manufacturing in region, with Mexico supporting our North American business, which is about 40% of Gentherm's total revenue. At this time, we believe we can largely mitigate the direct impact of tariffs. First, the majority of our components are either not included on the listed components annex or are USMCA compliant and therefore we do not expect significant incremental tariffs. However, for the tariffs we do incur, we have communicated to our customers these costs will be passed through. We have been working closely with our customers to implement tariff tracking and reimbursement mechanisms, and we have mapped out our production and flow of goods to provide our customers clear visibility to where the impacts are occurring. In some cases, we have changed logistics so that the customer becomes the importer of records, eliminating the need for any tariff pass through. We continue to keep a close eye on demand. We're closely watching dealer inventory levels, customer EDI schedules and collaborating with our customers to get real-time data on future demand. According to S&P Global's mid-April report, the outlook for 2025 annual volume has declined 2% for our relevant markets compared with the mid-February report. More notably, looking at the last three quarters of the year, the expected decline was 3.4% for our relative markets, including 10% in North America, where we have 40% of our business. In terms of direct insights from customers, there has been limited net impact from changes to demand schedules. For the year, we have assessed the latest light vehicle production forecasts and the impact of tariffs in place today, and while these put pressure on the midpoint of our initial revenue guidance, we are still within our prior range at this time. In summary, we have developed action plans to execute commercially and operationally based on the current environment. We are remaining nimble, allowing us to react to any policy changes that may occur. Even facing the current uncertainty, we remain confident that we are operating from a position of strength. Our balance sheet is very strong to weather any potential near-term noise. Longer term, we expect to grow revenue in automotive, medical and other markets, and we have a plan to expand margins and deliver strong free cash flows. Now let's turn to slide 4 to discuss our business and the things within our control. Since joining Gentherm on January 1, I have been continually impressed with the team by our product portfolio and our customer relationships. I have made multiple trips to our various locations around the globe to engage with the Gentherm team on the floors of our manufacturing facilities and technical centers. In addition, I have been meeting with our current and prospective customers as well as members of the investment community. Everything I have heard and seen has reinforced my belief that we have the right technology platforms that have a broad market application. As I said in our last earnings call, we are very focused on scaling our four core technology platforms: Thermal Management, Air Moving Devices, Pneumatic Solutions, and Valve Systems. The company has historically proven the portability of these technologies and ability to scale outside of the seat into other areas of the vehicle and into the medical market. Over the past 100 days, we have been mapping out opportunities into additional markets. I want to reinforce that the team has been acting with urgency to find new markets for existing product platforms while innovating new solutions for existing markets. I am very confident in our future growth, given recent automotive awards as well as our actions to identify opportunities in other markets. On slide 5, I want to give a real example of how we are identifying new growth opportunities. We have reinvigorated our product lifecycle roadmap with a key focus on our core technology platforms. This leads to clear visibility on the component and system level, which allows us to reach specifications or needs across various markets. That's a long-winded way of saying we can now spec our existing core technology platforms against other markets to buy and scale. Through some of our early work, we have already identified several new commercial opportunities utilizing our four core platforms and are now working through margin profiles and scenarios to see how we can accelerate our speed to market. Mapping our product platforms against conquest maps and commercial opportunities will be continuously sustained action to drive profitable growth. In a short time, we have been able to identify two areas for our medical business where we believe we can leverage our existing core platforms to address emerging needs in patient and physician thermal management. We are literally taking components used in automotive applications and redefining the usage of those same components to create new systems in medical. This is demonstrating that we can drive scale of our core products in other end markets without making significant incremental investments. We have completed proof of concepts on these product designs and are currently performing voice of the customer workshops to determine the potential for market adoption and pricing. The initial customer feedback has been very positive. These are two examples of opportunities to meaningfully expand our addressable market. Given these opportunities and others we are exploring, we have high aspirations for our medical business and believe it can scale to a much more meaningful percentage of our overall company revenue. This demonstrates how we are approaching growth opportunities with our methodical evaluation of all capabilities in our portfolio. As a technology leader, we believe we have the ability to unlock significant market potential that can change the growth trajectory of Gentherm. The medical example illustrates how we are fueling a key piece of the strategic framework that we rolled out across the company in March. On the left side of Slide 6, you see that our framework to deliver shareholder value focuses on profitable growth, operational excellence, and financial performance. On the right side are some of our initial key focus areas. As I said earlier, I am confident in our ability to scale Gentherm platforms for profitable growth. In addition to reshaping our product lifecycle management actions, we have been defining the size of the markets for our platforms and products outside of purely automotive. We have met with potential customers and partners in adjacent markets to define paths to push our technology into other applications. We are committed to driving profitable growth, and our product platforms and pipeline are the key to achieving that commitment. In addition, we have made progress on improving operational excellence and vigor. Visits to our global locations have provided us with clear insights on opportunities to drive continuous improvements. We are doing this through the implementation of standardized business processes. Early focus has been on standardized production control plans to bring inventory levels to an appropriate level based on a supply chain model we call 'Plan for Every Part'. These actions are supported by the standardized factory floor KPIs we have rolled out across the company that allow us to quickly benchmark our sites against one another. As previously announced, we have accelerated our strategic footprint plans that will realign our production across all three regions and optimize capacity. As a reminder, in North America, we are consolidating our two sites in Monterrey. In Europe, we will close our location in the Czech Republic and consolidate that production into North Macedonia and Morocco. In Asia, we are transferring production from one of our facilities in Shanghai to Tianjin. This quarter, we received production park approval in our Morocco facility and began shipping production components to the customer locations. This was a critical achievement to start ramping up our Morocco facility. These investments in our footprint position us for long-term margin expansion and free cash flow generation. A continued focus on product, operational excellence, and maximizing our usage of plant property and equipment would deliver superior financial performance. We have kicked off several work streams to identify areas where we can enhance cash flows. We are driving better utilization of our existing capital and will be diligent in our capital expenditures going forward to ensure we are efficiently utilizing our cash flow. We're also looking at things like our entity structure to identify where we can generate cash savings. Let's turn to the first quarter highlights on slide 7 before handing over to Jon, I want to share a few key performance highlights for the quarter. We continue to make strong commercial progress towards driving strategic profitable growth and saw solid new business awards in the quarter. The team continues to focus on driving operational and financial improvement even in light of a challenging environment, and we are investing in our business to make the right strategic moves to best position us for the future. We will not overreact to current near-term noise. Our priorities remain clear, scaling our technologies and optimizing our operations. Gentherm has unique capabilities, strong operating momentum, and additional paths for growth going forward. I am confident in our ability to succeed and drive shareholder value. And now I will turn the call over to Jon to review the first quarter highlights and results.

Thanks, Bill. Please turn to Slide 8. In the first quarter, our team delivered overall results that were in line with our expectations despite a highly dynamic operating environment. As we have continued diving into the business, it is clear there is a solid foundation in place that positions us well for long-term value creation. A key piece of the foundation is commercial success, and our team had another solid quarter to start the year. In total, we secured $400 million of automotive new business awards, which included multiple strategically important wins. We were awarded our first ever Pneumatic Comfort Solutions Award with a Japanese OEM, which is a significant milestone for two reasons. First, we previously stated that partnering with Japanese OEMs was key for Gentherm's growth and customer diversification, and this award demonstrates the significant progress we have made. Second, it is another example of the value of the Alfmeier acquisition and a great proof point of our ability to leverage Gentherm's strong customer relationships. This was a great win for the Japan team and we believe it is just the beginning of our efforts to expand our global business with the Japanese OEMs. In addition, we secured our first climate-controlled seat award with Volvo on a future vehicle platform. This award was a conquest win for Gentherm and an important first step as we look to grow our relationship with Volvo. In China, we secured several awards in the quarter with domestic OEMs including Great Wall, MI Auto, and Leap Motor. As we discussed on our last call, it is a priority for us to shift our China mix towards domestic OEMs to be more closely aligned to the overall market. While the mix is not yet where we wanted, we were pleased to see further progress in the quarter. Operationally, our team continued to successfully execute new program launches with 17 in the quarter across 11 OEMs. Key highlights include the launch of our entire suite of climate and comfort solutions products on the Lincoln Navigator and Ford Expedition including climate-controlled seats, lumbar and massage comfort solutions, climate-controlled interiors, and electronics. This launch highlights not only our strong relationship with Ford but also the strength of our industry-leading technology portfolio. Additionally, we began production of our thermal and pneumatic solutions on the Audi Q5 as well as a high-volume vehicle from a global EV manufacturer. We also launched several thermal components with Chinese domestic OEMs including with BYD, which will continue to support our growth efforts in China. Before closing this slide, I want to take the opportunity to acknowledge our global team for being recognized as General Motors Supplier of the Year. We appreciate the exclusivity of this award and are proud to have been selected for the third time. Our long-standing relationship with GM is built on innovative technology and strong business performance. We have a shared vision of delivering meaningful solutions that create value for GM and for the end consumer and look forward to continuing our strong partnership. Please turn to slide 9 for a more detailed review of the financial results for the quarter. First quarter revenues decreased 0.6% compared to the same period last year, but grew approximately 1% when adjusted for foreign exchange. Automotive climate and comfort solutions revenue increased 3.8% year-over-year or 5.3% ex-FX, outpacing actual light vehicle production in our key markets by more than 300 basis points driven by strong growth in lumbar and massage comfort solutions, partially offset by the expected declines in other automotive revenues. Our medical team delivered another strong quarter with improved financial performance. For the first quarter, revenues increased 6% ex-FX compared to the same period last year driven by growth in Europe. Turning to profitability, we delivered $39.3 million of adjusted EBITDA in the quarter or 11.1% of sales compared to 12.2% in the first quarter of last year. The decrease was primarily driven by higher freight costs, product mix, and the costs related to our footprint realignment, partially offset by strong net material performance. Adjusted operating expenses were approximately flat versus the prior year quarter. Adjusted diluted earnings per share in the quarter was $0.51 per share compared to $0.62 per share in the first quarter of last year. Our balance sheet and overall financial position remains strong. In the quarter, we saw an operating cash outflow consistent with prior year while investing approximately $11 million in net CapEx. Overall, net debt stood at $99 million and our net leverage ratio was 0.5 turns flat versus last year. Our available liquidity was approximately $400 million at the end of the quarter in line with prior year. Please turn to slide 10 for further context on our guidance. The operating backdrop has become increasingly dynamic and uncertain as the year progresses. After reviewing key variables impacting our business, we are maintaining our prior revenue range and reducing the low end of the adjusted EBITDA margin range to reflect the impact of lower volumes and current pass-through. The key assumptions that support our guidance are as follows: on tariffs, we are considering tariffs that are in effect as of today. As Bill mentioned earlier, our primary exposure relates to our Mexico operations where we are selling products into the U.S. for any tariffs incurred, with every indication that Gentherm will be able to pass through and recover the incremental costs. Similar to other forms of customer recovery, we may experience timing disconnects between when costs are incurred and ultimately settled with the customer. Our team is working closely with customers and suppliers to minimize the impact of Gentherm. Turning to volume, consistently, recent industry reports indicate that global full-year vehicle production will decline further than previously anticipated. To date, we have seen limited changes in OEM demand schedules with isolated increases and decreases resulting in an overall net impact that has been relatively unchanged. In reviewing recent industry reports, specifically we would note that S&P Mobility's mid-April report projected a 2% reduction in global light vehicle production versus their February report. This decline included a 10% reduction in North America volumes across the last three quarters of the year. As noted earlier, North America is approximately 40% of our total company revenue. Additionally, we have seen recent changes in foreign currencies versus the dollar, which we expect will have a favorable impact on the company. In summary, we expect lower revenue from the decline in vehicle volume with partial offsets from tariff pass-through and foreign exchange favorability. Overall, we expect this to pressure margin and have updated our guidance accordingly. As we navigate through this period, we are fortunate to have a strong balance sheet allowing us to focus on growth, improve overall financial performance, and invest in the future. We will continue to closely monitor market dynamics and will provide updates as appropriate. With that, I will hand it back to Bill for closing remarks.

Thanks, Jon. Let me wrap up with why I believe Gentherm remains a compelling long-term opportunity. First, we're innovative leaders uniquely positioned for profitable growth driven by scalable technology platforms and broad market applications. The company's strong R&D mindset has built the foundation of our key platforms including thermal management, air moving devices, pneumatic solutions, and valves. Our innovative and differentiated technologies are scalable and portable to adjacent markets. Our commercial success is within our control and not dependent on a Tier-1 to sell our products. We work directly with OEMs to capture the voice of the customer and bring our products to market to provide the OEMs with unique differentiated selling points. Next, we have a continuous improvement mindset to drive margin expansion and solid cash flow conversion. Our strategic footprint realignment is underway which will lower our variable manufacturing costs and allow us to leverage our fixed cost structure on higher future revenue. The margin profile of our lumbar and massage comfort solutions continues to expand as we wind down pre-acquisition business contracts and launch new business from the awards we secured after the acquisition. Lastly, we have a strong financial position with the ability to efficiently deploy capital and drive shareholder value. This will allow us to remain flexible and opportunistic with our capital allocation priorities. I remain optimistic about the future of Gentherm. As we work to navigate through some of the near-term noise, we are confident in the opportunities to generate shareholder value. We look forward to keeping you informed of our progress throughout the year. With that, I will turn the call back to the operator to begin the Q&A session.

The first question is from Ryan Sigdahl from Craig-Hallum Capital Group. Please go ahead.

Hey, good morning guys. Appreciate the update on certainly a lot going on in the industry right now and the world. Want to start with the guidance and the tariff impact. So how much pass through revenue is incorporated in the guidance and then with the decremental margin on the low end of the EBITDA guidance, how much of that is pass through revenue versus core operating performance?

Hey Ryan, good morning. Regarding the tariffs we discussed, we're currently focused on those that are in place today, which represent a smaller portion of what may come. We aimed to outline that the overall impact is concentrated more on Mexico and North America, where about 40% of our total business operates. Currently, the impact from the tariffs is relatively minor in terms of what we are passing through. There may be a couple of basis points of impact on dilution, but it's not significant. The main area of uncertainty lies in the industry volumes and their effects. We were quite clear in presenting that.

Yes, thanks, Jon. As you. Excuse me. As you think about medical and you talked a lot about adjacencies you have since you guys have come in here, the opportunity to expand into other automotive, but also non-automotive medical applications. Gentherm going back over the past decade has tried this in the past to then kind of refocus the business back on core markets over the past several years, I guess. Why is this different? How do you think about staying focused, really doing this in an efficient, smart and strategic way. But just any clarity, kind of looking at Gentherm over the past 10 years and trying to get into adjacent markets versus what you guys are looking at now.

Yes. Ryan, good morning. Bill, good to hear from you. Yes, let me be clear. I think in the past when we've looked at it, there was a push into adjacent markets, as you've said. But our focus is very different. Our focus is taking the core technology platforms and pushing those specifically into adjacent markets. And just to be super clear, the two proof of concepts we talk about in medical, what's important there is the methodology we went through to create these new proof of concepts. So we talk about surgeon and patient warming. We have literally 100% taken the heating technology that we use in the seating, which is the same heating technology that we use in the steering wheels, which is the same heating technology that we use in climate and comfort interiors, and found an application for that exact same technology, unadulterated, other than shape, for the medical market. So this is really an approach not about new products for new markets, but about scaling existing technologies, utilizing existing floor space and existing capital equipment and pushing them into new markets. So it's, it's a very different approach. And you and I talked and you've heard me say this, if it's the exact same technology, don't care what market it's in as long as it's coming off the same machine in my plants.

Very helpful. Thanks, Bill. Good luck, guys.

The next question is from Matt Koranda from Ross Capital. Please go ahead.

Good morning, everyone. It's Joseph in for Matt today. Regarding your new program awards, it seems that the figures for this quarter are among the lowest since 2022. Could you elaborate on the booking dynamics in the first quarter? Were there fewer programs available for bidding?

Yes. I would say it's been in line. I mean, historically with what we've done in Q1, if you go back and look through history, we've had some hot months just based on our hot quarters in the past, based on what was awarded. But I would say the first quarter came in right about where we expected it to come in. So while it might look a little light, it was exactly what we expected based on the texturing we see in our roadmaps for when the original equipment manufacturers are asking us to quote. So with all that said, everything we see full year, we have a very rigorous process for how we map out our opportunities and when they're available and how we're going to quote them and address them, says we should have a very robust year again this year. I see nothing that says different.

Got it. Thank you for that. And then if I could just squeeze in one more on your 2025 guide. Just looks like the revenue guide remains unchanged despite the weaker industry forecast. Could you just speak on what's enabling you guys to hold up sales? The sales guide remains unchanged despite the erosion in the production expectations, especially in the North American market.

Yes, I think as we look at the guidance, the prior midpoint was 1450. Current midpoint is 1450. I think, the biggest piece of that is the North American volume which we highlighted. I think we put information out there in the back in terms of the amount North America contributes to the business, what industry reports we're looking at in terms of 10% declines for the balance of the year. And it, that certainly puts pressure or takes our midpoint guidance down to the lower end. We do see some, some favorability from FX will offset, which will offset a portion of that. We will see the pass-through recovery of tariffs impacting revenue as well. And so as we've looked at it, particularly with the uncertainty on where industry volumes will actually come in we put that map together and said we'll still be in the range, albeit it may be towards the lower end of that range, but still comfortable putting that out there given the fact that there's so many moving dynamics right now.

I appreciate it, Jon. Thank you.

The next question is from Ryan Brinkman from JPMorgan. Please go ahead.

Great. Thanks for taking my questions, starting with I'm curious if you might have seen any benefit during the quarter from automaker orders for parts exceeding what they would ordinarily purchase to support concurrent production as they sought to maybe atypically stockpile components ahead of production in an effort to mitigate tariff impact. Is that something that you're seeing?

I haven't really seen anything meaningful on the production side. I would say the variances that we saw in production orders from the customer in the first quarter fell within what we consider to be standard variances. So we haven't seen a heavy pull to try to stock ahead of the tariffs.

That's helpful, thanks. Firstly, relative to the comment that many or most of your products are not subject to tariffs because they are either not included in the categories of tariff components or because they are USMCA compliant, are you able to say how much is because they are not in the tariff categories versus how much is because they are USMCA compliant? And then secondly, and relatedly relative to your comment that the guide incorporates tariffs in effect as of today, does that assume then that the temporary exemption on USMCA compliant parts that last through May 3rd, that that continues, or do you assume that the exemption period ends or how to think about that?

Yes, I mean, I think as we look at it, we're certainly not going to predict what direction these things go, just based on the changes that happen seemingly by the day here. I think where, as we look at it, we sort of take comfort in what we talked about in the prepared remarks is we have the mechanisms in place to be able to recover these and are working with customers closely to be able to do that. And so to the extent that those go into effect, there would be more expense incurred that would be, we'd expect to fully pass on to the customers and therefore recover. So the dilution impact on the margin would be a little bit higher than what we've contemplated in the range. But we still feel by tweaking the lower end of the range that we're still within that 11.5% to 13% from an adjusted EBITDA perspective for the year.

Great. Very helpful. Thanks so much.

This concludes the question-and-answer session as well as today's call. You may disconnect your lines at this time. Thank you for your participation.